English

GENERATION BIO CO.

EDGAR

GBIO Current report (8-K) · filed 2026-02-09

Annual consolidated revenue for 2024: about Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 19.89M, using the latest reported figures. The previous period, 2023, was about Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 5.904M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.59 million Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg

2025 Q3 · Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg

Exact inputs and evidence

Revenue: 1594000 Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg Source

Operating margin

-420.83%

2025 Q3 · %

Exact inputs and evidence

Operating Income: -6708000 Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg Source
Revenue: 1594000 Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg Source

Cash and cash equivalents: 21.9 million Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg 2025-09-30 Source
Exact value

21940000 Unit_Standard_USD_-prKX-2LOEmWf2EDPanzzg
Long-term debt including current maturities: Not available
Shares outstanding: 6.74 million Unit_Standard_shares_OqjfNOtxek2MvSIBKffUUg 2025-09-30 Source
Exact value

6735676 Unit_Standard_shares_OqjfNOtxek2MvSIBKffUUg

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-02-09.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2024-12-31
Operating income: 3 of 11 periods available· newest 2024-12-31
Net income: 3 of 11 periods available· newest 2024-12-31
Operating cash flow: 3 of 11 periods available· newest 2024-12-31
Capital expenditure: 3 of 11 periods available· newest 2024-12-31
Total assets: Multiple units; comparison withheld· newest 2024-12-31
Total liabilities: Multiple units; comparison withheld· newest 2024-12-31
Current assets: Multiple units; comparison withheld· newest 2024-12-31
Current liabilities: Multiple units; comparison withheld· newest 2024-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2024-12-31
long term debt: No compatible figures in this window
Shares outstanding: Multiple units; comparison withheld· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+236.9%

Prior period

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 5.9 million

2023-01-01 – 2023-12-31
Current period

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 19.89 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

19892000 − 5904000 = 13988000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA

5904000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
19892000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Year-over-year change in Revenue: 13988000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 19892000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1500804 Filing: 000155837025002907 Input fundies:Revenue: 5904000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1501806 Filing: 000155837025002907
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 5.09 million

Prior period

−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 126.61 million

2023-01-01 – 2023-12-31
Current period

−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 131.7 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-131700000 − -126612000 = -5088000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA

-126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Year-over-year change in Net income: -5088000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1846942 Filing: 000155837025002907 Input fundies:NetIncome: -126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1543217 Filing: 000155837025002907
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 35.82 million

Prior period

−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 52.75 million

2023-01-01 – 2023-12-31
Current period

−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 88.56 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-88563000 − -52745000 = -35818000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA

-52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Year-over-year change in Operating cash flow: -35818000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1781544 Filing: 000155837025002907 Input fundies:OperatingCashFlow: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1782586 Filing: 000155837025002907
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-67.5%

Prior period

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 7.4 million

2023-01-01 – 2023-12-31
Current period

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2.4 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

2401000 − 7397000 = -4996000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA

7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Year-over-year change in Capital expenditure: -4996000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1787414 Filing: 000155837025002907 Input fundies:CapitalExpenditure: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1788382 Filing: 000155837025002907
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 19.89 million 100% of revenue
Operating costs Derived Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 162.28 million 816% of revenue
Operating income −Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 142.39 million −716% of revenue
Tax, interest and other Derived −Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 10.69 million −54% of revenue
Net income −Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 131.7 million −662% of revenue

Cash

Operating cash flow −Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 88.56 million −445% of revenue
Capital expenditure Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2.4 million 12% of revenue
Free cash flow Derived −Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 90.96 million −457% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2023 Operating loss: operating costs were 2,447% of revenue.
2024 Operating loss: operating costs were 816% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2023 2023-01-01 – 2023-12-31	5904000	144467000 Derived	-138563000	-11951000 Derived	-126612000	-60142000 Derived	Source 2023-01-01 – 2023-12-31: 5904000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Revenue Open source 2023-01-01 – 2023-12-31: -138563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Net Income Open source 2023-01-01 – 2023-12-31: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	19892000	162282000 Derived	-142390000	-10690000 Derived	-131700000	-90964000 Derived	Source 2024-01-01 – 2024-12-31: 19892000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Revenue Open source 2024-01-01 – 2024-12-31: -142390000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Net Income Open source 2024-01-01 – 2024-12-31: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Capital Expenditure Open source

Amounts are exact, in Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 19.9M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA)	Source evidence
20232023-12-31	Revenue	5904000	Revenue: 5904000 Open source
20242024-12-31	Revenue	19892000	Revenue: 19892000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

236.9% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20232023-12-31	Year over year	No prior comparable period	Revenue: 5904000 Open source
20242024-12-31	Year over year	236.9%	Revenue: 19892000 Open source Revenue: 5904000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -715.8% 2024

Net margin -662.1% 2024

Free cash flow margin -457.3% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20232023-12-31	Operating margin	-2,346.9%	Operating Income: -138563000 Open source Revenue: 5904000 Open source
20242024-12-31	Operating margin	-715.8%	Operating Income: -142390000 Open source Revenue: 19892000 Open source
20232023-12-31	Net margin	-2,144.5%	Net Income: -126612000 Open source Revenue: 5904000 Open source
20242024-12-31	Net margin	-662.1%	Net Income: -131700000 Open source Revenue: 19892000 Open source
20232023-12-31	Free cash flow margin	-1,018.7%	Revenue: 5904000 Open source Operating Cash Flow: -52745000 Open source Capital Expenditure: 7397000 Open source
20242024-12-31	Free cash flow margin	-457.3%	Revenue: 19892000 Open source Operating Cash Flow: -88563000 Open source Capital Expenditure: 2401000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA -88.6M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA)	Source evidence
20232023-12-31	Operating cash flow	-52745000	Operating Cash Flow: -52745000 Open source
20242024-12-31	Operating cash flow	-88563000	Operating Cash Flow: -88563000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA -91M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA)	Source evidence
20232023-12-31	Free cash flow	-60142000	Operating Cash Flow: -52745000 Open source Capital Expenditure: 7397000 Open source
20242024-12-31	Free cash flow	-90964000	Operating Cash Flow: -88563000 Open source Capital Expenditure: 2401000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2023-12-31	Liabilities / assets	Not reported	No source recorded
2024-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2023-12-31	Current assets / current liabilities	Not reported	No source recorded
2024-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2022 2022-01-01 – 2022-12-31	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 136.64 million Exact value Exact value: -136639000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2022-01-01 – 2022-12-31: -136639000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Net Income Open source Share or cite Citation for Net Income · GENERATION BIO CO. · 2022-12-31 GENERATION BIO CO. (edgar:1733294) Net Income: -136639000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:NetIncome: -136639000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1544163 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 102.45 million Exact value Exact value: -102448000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2022-01-01 – 2022-12-31: -102448000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENERATION BIO CO. · 2022-12-31 GENERATION BIO CO. (edgar:1733294) Operating Cash Flow: -102448000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:OperatingCashFlow: -102448000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1783669 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 8.8 million Exact value Exact value: 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2022-01-01 – 2022-12-31: 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENERATION BIO CO. · 2022-12-31 GENERATION BIO CO. (edgar:1733294) Capital Expenditure: 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:CapitalExpenditure: 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1789391 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 111.25 million Calculation and evidence -102448000 − 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Exact free cash flow: -111249000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2022-01-01 – 2022-12-31: -102448000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENERATION BIO CO. · 2022-12-31 GENERATION BIO CO. (edgar:1733294) Free cash flow: -111249000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -102448000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1783669 Filing: 000155837025002907 Input fundies:CapitalExpenditure: 8801000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1789391 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 126.61 million Exact value Exact value: -126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2023-01-01 – 2023-12-31: -126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Net Income Open source Share or cite Citation for Net Income · GENERATION BIO CO. · 2023-12-31 GENERATION BIO CO. (edgar:1733294) Net Income: -126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:NetIncome: -126612000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1543217 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 52.75 million Exact value Exact value: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2023-01-01 – 2023-12-31: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENERATION BIO CO. · 2023-12-31 GENERATION BIO CO. (edgar:1733294) Operating Cash Flow: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:OperatingCashFlow: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1782586 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 7.4 million Exact value Exact value: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2023-01-01 – 2023-12-31: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENERATION BIO CO. · 2023-12-31 GENERATION BIO CO. (edgar:1733294) Capital Expenditure: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:CapitalExpenditure: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1788382 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 60.14 million Calculation and evidence -52745000 − 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Exact free cash flow: -60142000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2023-01-01 – 2023-12-31: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENERATION BIO CO. · 2023-12-31 GENERATION BIO CO. (edgar:1733294) Free cash flow: -60142000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52745000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1782586 Filing: 000155837025002907 Input fundies:CapitalExpenditure: 7397000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1788382 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 131.7 million Exact value Exact value: -131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2024-01-01 – 2024-12-31: -131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Net Income Open source Share or cite Citation for Net Income · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Net Income: -131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:NetIncome: -131700000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1846942 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 88.56 million Exact value Exact value: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2024-01-01 – 2024-12-31: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Operating Cash Flow: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:OperatingCashFlow: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1781544 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2.4 million Exact value Exact value: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2024-01-01 – 2024-12-31: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Capital Expenditure: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA&dimensions= Input fundies:CapitalExpenditure: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1787414 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 90.96 million Calculation and evidence -88563000 − 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Exact free cash flow: -90964000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA 2024-01-01 – 2024-12-31: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENERATION BIO CO. · 2024-12-31 GENERATION BIO CO. (edgar:1733294) Free cash flow: -90964000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:03:47Z Snapshot: 231302d0470e3b4d628d1b34acf5d58a096368778831e0dde9d49cae0f6240c0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733294?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -88563000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1781544 Filing: 000155837025002907 Input fundies:CapitalExpenditure: 2401000 Unit_Standard_USD_BKdTalVYTkarN98l9MXDVA (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733294/000155837025002907/gbio-20241231x10k.htm#1787414 Filing: 000155837025002907 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

26 filings · 2,675 latest values · 2,675 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001733294, 1733294, GBIO, edgar:1733294

Also known as GENERATION BIO CO., Generation Bio Co.

GENERATION BIO CO.

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation